Eli Lilly has unveiled a new weight loss drug that appears to be delivering the highest weight loss yet in clinical trials ...
Forbes contributors publish independent expert analyses and insights. Peter Cohan, a Boston-based senior contributor, covers stocks. Eli Lilly achieved a $1 trillion market cap, a healthcare first, ...
Nov 21 (Reuters) - Eli Lilly (LLY.N), opens new tab hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its ...
The pop star, who has been sober since 2019, spoke to 'CBS Mornings' about her latest album 'West End Girl' Ilana Kaplan is a Staff Editor at PEOPLE. She has been working at PEOPLE since 2023. Her ...
Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse. A more ...
The world’s largest drugmaker, Eli Lilly & Co., just notched another milestone: it’s the first health-care company to cross the $1 trillion threshold as investors bet big on the drugmaker’s ...
Eli Lilly and Co (NYSE: LLY) shares are trading higher on Friday. The company plans to start selling its obesity drug through a new approach aimed at expanding access. What To Know: Eli Lilly is ...
The 150-year-old drugmaker is the first company in health care to hit the milestone. By Rebecca Robbins Eli Lilly, the maker of hugely popular weight loss drugs, has reached $1 trillion in value, ...
Lily Allen is set to take her critically acclaimed third studio album, West End Girl, to arenas across the UK and Ireland next summer. The announcement follows the runaway success of West End Girl, ...
Sen. Ruben Gallego (D-Ariz.) is asking for more information on Eli Lilly’s recently announced agreement with the Trump administration regarding the sale of its GLP-1 medication. In a letter to Lilly ...
Eli Lilly shares rose again Tuesday, their sixth increase in the past seven sessions. The drugmaker's market cap also closed at a record, $973.8 billion, as Lilly inched closer to the $1 trillion ...
South Korea’s newest billionaire is Lee Sang-hoon, founder of Seoul-based ABL Bio, after it struck a $2.6 billion licensing and joint research deal with Eli Lilly for its bispecific antibody ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results